Seegene Completes IPO, Raises $16.6M

The Korean molecular diagnostics firm is listed on the KOSDAQ and will use funds from its IPO to further expand its footprint globally, it said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories